Related Experiment Video
Updated: Jun 5, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Continuous infusion of a standard combination solution in the management of hyperkalemia
Halima S Janjua1, John D Mahan, Hiren P Patel
1Division of Nephrology, Department of Pediatrics, Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA.
Insights
Continuous infusion of HyperK-Cocktail, a combination therapy for hyperkalemia, effectively and safely lowers potassium levels in children. This treatment offers a promising approach for managing this life-threatening electrolyte imbalance.
Area of Science:
- Pediatric Nephrology
- Emergency Medicine
- Clinical Pharmacology
Background:
- Hyperkalemia is a critical electrolyte disorder impacting cardiac function.
- Prompt management of hyperkalemia is essential to prevent life-threatening complications.
- Various therapeutic agents are available for hyperkalemia treatment, often used in combination.
Purpose of the Study:
- To evaluate the safety and efficacy of a continuous infusion of a fixed-concentration solution (HyperK-Cocktail) for treating hyperkalemia.
- To assess the impact of HyperK-Cocktail on serum potassium levels and identify potential adverse events.
Main Methods:
- A continuous infusion of HyperK-Cocktail (calcium gluconate, insulin, dextrose, sodium acetate) was administered to 21 hyperkalemic patients on 23 occasions.
- Treatment continued until plasma potassium levels stabilized.
- Patient outcomes, including serum potassium changes and adverse events, were monitored.
Main Results:
- HyperK-Cocktail infusion resulted in a significant decrease in serum potassium levels over 8 hours.
- Mean potassium reduction was 1.0, 1.7, 2.1, and 2.1 mmol/L at 1, 2, 4, and 8 hours, respectively.
- No instances of intravenous extravasation, hypernatremia, hypocalcemia, hypercalcemia, or alkalosis were observed; transient hyperglycemia and one case of hypoglycemia occurred.
Conclusions:
- HyperK-Cocktail is a safe and effective combination therapy for pediatric hyperkalemia.
- The continuous infusion approach demonstrates a sustained reduction in potassium levels.
- This treatment offers a valuable option for managing hyperkalemia in children.
Background:
Hyperkalemia, due to its effect on cardiac conductivity, is a potentially life-threatening electrolyte abnormality. Multiple therapeutic agents may be used alone or in combination for its prompt management.
Methods:
We report on the safety and efficacy of continuous infusion of a solution containing fixed concentrations of calcium gluconate, insulin, dextrose and sodium acetate (HyperK-Cocktail) for the treatment of hyperkalemia. This solution is prepared at our institution and is infused parenterally until the plasma potassium level stabilizes. Twenty-one consecutive hyperkalemic patients managed with HyperK-Cocktail on 23 occasions are reported.
Results:
None of the subjects had intravenous extravasation injuries, hypernatremia, hypocalcemia, hypercalcemia or alkalosis during HyperK-Cocktail infusion. Transient hyperglycemia developed in nine subjects and hypoglycemia in one subject. The decrease in serum potassium was similar in the initial hour when compared to prior studies using a beta-agonist and/or insulin and glucose; a larger decrease was present from 2 to 8 h with the HyperK-Cocktail. The plasma potassium decreased by a mean of 1.0, 1.7, 2.1 and 2.1 mmol/L at 1, 2, 4 and 8 h, respectively. The mean serum potassium at hours 1-8 was significantly lower than the initial level.
Conclusion:
The results of our study demonstrated that HyperK-Cocktail is a safe and effective combination therapy for children with hyperkalemia.
Related Concept Videos
Acute Kidney Injury V: Interprofessional Care
One-Compartment Model: IV Infusion
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
Acute Kidney Injury VI: Nursing Management
Continuous Renal Replacement Therapy
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
